Bunyaviral Fevers: Rift Valley Fever and Crimean-Congo Hemorrhagic Fever

Tropical Infectious Diseases

Volumn 1, Issue , 2006, Pages 756-761

  Watts, Douglas M ^a,b   Flick, Ramon ^b   Peters, C J ^c   Shope, Robert E ^b  

^a WHO Collab Center for Tropical Dis   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882486898     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06668-9.50072-7     Document Type: Chapter

References (57)

1. Schmaljohn CS, Hooper JW Bunyaviridae: the viruses and their replication. Fields' Virology 2001, 1581. Williams and Wilkins, Philadelphia, Lippincott. 4th ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin (Eds.).
2. Control of Communicable Diseases Manual 2000, 33. American Public Health Association, Washington, DC. 17th ed. J. Chin (Ed.).
3. Peters CJ, Linthicum KJ Rift Valley fever. Handbook Series of Zoonoses, Section B: Viral Zoonoses 1994, 125. CRC Press, Boca Raton, FL. 2nd ed. G.W. Beran (Ed.).
4. Daubney R, Hudson JR, Garnham PC Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa. J PathoI 1931, 34:545.
5. Meegan JM, Shope RE Emerging concepts on Rift Valley fever. Perspect Virol 1981, 11:267.
6. Digoutte JP, Peters CJ General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res Virol 1989, 140:27.
7. Peters CJ Emergence of Rift Valley fever. Factors in the Emergence of Arbovirus Diseases 1997, 253. Elsevier, Paris. J.F. Saluzzo, B. Dodet (Eds.).
8. Arthur R, Ei-Sharkawy MS, Cope SE, et al. Recurrence of Rift Valley fever in Egypt. Lancet 1993, 342:1149.
9. Abd el-Rahim IH, Abd el-Hakim U, Hussein M An epizootic of Rift Valley fever in Egypt in 1997. Rev Sci Tech 1999, 18:741.
10. Fagbo SF The evolving transmission pattern of Rift Valley fever in the Arabian Peninsula. Ann NY Acad Sci 2002, 969:201.
11. Linthicum KJ, Davies FG, Kairo A, et al. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus): Isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg 1985, 95:197.
12. Chumakov MP Contribution to 30 years of investigation of Crimean haemorrhagic fever. Med Virol 1974, 22:5.
13. Leshchinskaya EV Clinical picture of Crimean hemorrhagic fever (in Russian). Trudy Inst Polio Virusn Entsefalitov Akad Med Nauk SSSR 1965, 7:226. (in English: NAMRU3-1856),.
14. Casals J Antigenic similarities between the virus causing Crimean hemorrhagic fever and Congo virus. Proc Soc Exp Biol Med 1969, 131:233.
15. Hoogstraal H The epidemiology of tick-borne Crimean-Congo haemorrhagic fever in Asia, Europe and Africa. J Med Entomol 1979, 15:307.
16. Watts DM, Ksiazek TG, Linthicum KJ, et al. Crimean-Congo hemorrhagic fever. The Arboviruses: Epidemiology and Ecology 1989, II:177. CRC Press, Boca Raton, FL. T.G. Monath (Ed.).
17. Casals J, Tignor GH The Nairovirus genus: serological relationships. Intervirology 1980, 14:144.
18. Scrimgeour EM Crimean-Congo haemorrhagic fever in Oman. Lancet 1996, 347:692.
19. Mardani M, Jahromi MK, Naieni KH, et al. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis 2003, 36:1613.
20. Khan AS, Maupin GO, Rollin PE, et al. An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg 1997, 57:519.
21. Bumey MI, Ghafoor A, Saleen M, et al. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever-Congo virus in Pakistan. Am J Trop Med Hyg 1976, 29:941.
22. Laughlin LW, Watten RH Epidemic of Rift Valley fever in Egypt: observations on the spectrum of human illness. Trans R Soc Trop Med Hyg 1979, 76:630.
23. Al Hazmi M, Ayoola EA, Abduraham M, et al. Epidemic of Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 2003, 36:245.
24. Madani TA, Al-Mazrou YY, Al-Jeffri MH, et al. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 2003, 37:1084.
25. Swanepoel R, Shepherd AJ, Leman PA, et al. Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg 1987, 36:120.
26. Peters CJ Viral hemorrhagic fevers. Viral Pathogenesis 1997, 799. Lippincott-Raven, Philadelphia. N. Nathanson, R. Ahmed, F. Gonzales-Scarano (Eds.).
27. Morrill JC, Jennings GB, Johnson AJ, et al. Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch Virol 1990, 110:195.
28. Cosgriff TM, Morrill JC, Jennings GB, et al. Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys. Rev Infect Dis 1989, 11(Suppl 4):S807.
29. Peters CJ, Jones D, Trotter R, et al. Experimental Rift Valley fever in rhesus macaques. Arch Virol 1988, 99:31.
30. Anderson GW, Slone TW, Peters CJ Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats. Microbiol Pathog 1987, 2:283.
31. van Velden DJ, Meyer JD, Olivier J, et al. Rift Valley fever affecting humans in South Africa: a clinicopathological study. S Afr Med J 1977, 51:867.
32. Anderson GW, Slone TW Peters CJ: The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis. Arch Virol 1988, 102:187.
33. Morrill JC, Peters CJ Pathogenicity and neurovirulence studies of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 2003, 21:2994.
34. Cohen C, Luntz MH Rift Valley fever and rickettsial retinitis including fluorescein (author's transl). [German]. Klin Monatsbl Augenheilkd 1976, 169:685.
35. Pittman PR, Liu CT, Cannon RS, et al. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 1999, 18:181.
36. Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989, 11:S794.
37. Gear JHS Crimean-Congo hemorrhagic fever. CRC Handbook of Viral and Rickettsial Hemorrhagic Fevers 1986, 121. CRC Press, Boca Raton, FL. J.H.S. Gear (Ed.).
38. Burt FJ, Leman PA, Smith JF, et al. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods 1998, 70:129.
39. Burt FJ, Swanepoel R, Shieh W-J, et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 1997, 121:839.
40. Schwarz TF, Nitschko H, Jager G, et al. Crimean-Congo haemorrhagic fever in Oman. Lancet 1995, 346:1230.
41. Shepherd AJ, Swanepoel R, Leman PA Antibody response in Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989, 11(Suppl 4):801.
42. Drosten CS, Gottig S, Schilling M, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcripttion-PCR. J Clin Microbiol 2002, 40:2323.
43. Garcia S, Crance JM, Billecocq A, et al. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J Clin Microbiol 2001, 39:4456.
44. Swanepoel R, Struthers JK, Erasmus MJ, et al. Comparison of techniques for demonstrating antibodies to Rift Valley fever virus. J Hyg 1986, 97:317.
45. Paweska JT, Burt FJ, Anthony F, et al. IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants. J Virol Methods 2003, 113:103.
46. Dykewicz CA, Shope RE Viral hemorrhagic fevers. Current Therapy of Infectious Disease 1996, 515. Mosby-Year Book, St. Louis. D. Schlossberg (Ed.).
47. Peters CJ, Reynolds JA, Slone TW, et al. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res 1986, 6:285.
48. Morrill JC, Jennings GB, Cosgriff TM, et al. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Rev Infect Dis 1989, 11(Suppl 4):S815.
49. Watts DM, Ussery MA, Nash D, et al. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg 1989, 41:591-595.
50. Paragas J, Whitehouse CA, Endy TP, et al. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res 2004, 62:21.
51. Tignor GH, Hanham CA Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res 1993, 22:309-325.
52. Fisher-Hoch SP, Khan JA, Rehman S, et al. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 1995, 346:472.
53. Papa A, Bozovi B, Pavlidou V, et al. Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis 2002, S8:852.
54. Vassilenko SM, Vassilev TL, Bozadjiev LG, et al. Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet 1990, 335:791.
55. Vassilev T, Valchev V, Kazarov G, et al. A reference preparation for human immunoglobulin against Crimean/Congo hemorrhagic fever. Biologicals 1991, 19:57.
56. Huggins JW Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad spectrum antiviral drug. Rev Infect Dis 1989, 11:S750.
57. Management of patients with suspected viral hemorrhagic fever. MMWR 1988, 37:1. Centers for Disease Control and Prevention.